SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    F. Eskandary, M. Wahrmann, P. Biesenbach, C. Sandurkov, F. Konig, E. Schwaiger, T. Perkmann, S. Kunig, K. Derfler, G. J. Zlabinger, G. A. Bohmig, ABO antibody and complement depletion by immunoadsorption combined with membrane filtration--a randomized, controlled, cross-over trial, Nephrology Dialysis Transplantation, 2014, 29, 3, 706

    CrossRef

  2. 2
    Carrie Schinstock, Mark D. Stegall, Acute Antibody-Mediated Rejection in Renal Transplantation: Current Clinical Management, Current Transplantation Reports, 2014, 1, 2, 78

    CrossRef

  3. 3
    Maha A. Al-Mohaissen, Sean A. Virani, Allosensitization in Heart Transplantation: An Overview, Canadian Journal of Cardiology, 2014, 30, 2, 161

    CrossRef

  4. 4
    Mark Haas, An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts, Current Opinion in Organ Transplantation, 2014, 19, 3, 315

    CrossRef

  5. 5
    Manuel Arias, David N. Rush, Chris Wiebe, Ian W. Gibson, Tom D. Blydt-Hansen, Peter W. Nickerson, Joana Sellarés, Marcos López-Hoyos, David San Segundo, María G. Crespo-Leiro, Raquel Marzoa-Rivas, Eduardo Barge-Caballero, María J. Paniagua-Martín, Antonio Román, Daniel Serón, Georg Böhmig, Elisabeth Schwaiger, Antibody-Mediated Rejection, Transplantation, 2014, 98, S3

    CrossRef

  6. 6
    Andrew Bentall, Dolly B. Tyan, Flavia Sequeira, Matthew J. Everly, Manish J. Gandhi, Lynn D. Cornell, Han Li, Nicole A. Henderson, Suresh Raghavaiah, Jeffrey L. Winters, Patrick G. Dean, Mark D. Stegall, Antibody-mediated rejection despite inhibition of terminal complement, Transplant International, 2014, 27, 9
  7. 7
    Timucin Taner, Mark D. Stegall, Julie K. Heimbach, Antibody-mediated rejection in liver transplantation: Current controversies and future directions, Liver Transplantation, 2014, 20, 5
  8. 8
    Thomas D Barbour, Amy Crosthwaite, Kevin Chow, Moira J Finlay, Nathan Better, Peter D Hughes, Solomon J Cohney, Antiphospholipid syndrome in renal transplantation, Nephrology, 2014, 19, 4
  9. 9
    Han Li, Mark D. Stegall, Patrick G. Dean, Edward T. Casey, Kunam S. Reddy, Hasan A. Khamash, Raymond L. Heilman, Martin L. Mai, C. Burcin Taner, Catherine L. Kosberg, Lisa L. Bakken, Elmira J. Wozniak, Kathleen L. Giles, Lisa A. Veal, Manish J. Gandhi, Fernando G. Cosio, Mikel Prieto, Assessing the Efficacy of Kidney Paired Donation—Performance of an Integrated Three-Site Program, Transplantation, 2014, 98, 3, 300

    CrossRef

  10. You have free access to this content10
    Sarah Stevenson, Andrew Mallett, Kimberley Oliver, Valentine Hyland, Carmel Hawley, Theo Malmanche, Nicole Isbel, Atypical HUS associated with severe, unexpected antibody-mediated rejection post kidney transplant, Nephrology, 2014, 19,
  11. 11
    Hefziba Green, Emanuel Harari, Miriam Davidovits, Dorit Blickstein, Alon Grossman, Uzi Gafter, Anat Gafter-Gvili, Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumab, Renal Failure, 2014, 36, 7, 1119

    CrossRef

  12. 12
    M. Haas, B. Sis, L. C. Racusen, K. Solez, D. Glotz, R. B. Colvin, M. C. R. Castro, D. S. R. David, E. David-Neto, S. M. Bagnasco, L. C. Cendales, L. D. Cornell, A. J. Demetris, C. B. Drachenberg, C. F. Farver, A. B. Farris, I. W. Gibson, E. Kraus, H. Liapis, A. Loupy, V. Nickeleit, P. Randhawa, E. R. Rodriguez, D. Rush, R. N. Smith, C. D. Tan, W. D. Wallace, M. Mengel, Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions, American Journal of Transplantation, 2014, 14, 2
  13. 13
    Ryszard Grenda, Biologics in renal transplantation, Pediatric Nephrology, 2014,

    CrossRef

  14. 14
    Farsad Eskandary, Gregor Bond, Elisabeth Schwaiger, Zeljko Kikic, Christine Winzer, Markus Wahrmann, Lena Marinova, Helmuth Haslacher, Heinz Regele, Rainer Oberbauer, Georg A Böhmig, Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial, Trials, 2014, 15, 1, 107

    CrossRef

  15. 15
    Yu-gang Zhao, Bing-yi Shi, Ye-yong Qian, Hong-wei Bai, Li Xiao, Xiu-yun He, Clinical efficacy of rituximab for acute rejection in kidney transplantation: a meta-analysis, International Urology and Nephrology, 2014, 46, 6, 1225

    CrossRef

  16. 16
    Paolo Cravedi, Peter S. Heeger, Complement as a multifaceted modulator of kidney transplant injury, Journal of Clinical Investigation, 2014, 124, 6, 2348

    CrossRef

  17. 17
    Maxime Touzot, Erika Nnang Obada, Severine Beaudreuil, Hélène François, Antoine Durrbach, Complement modulation in solid-organ transplantation, Transplantation Reviews, 2014, 28, 3, 119

    CrossRef

  18. 18
    Andrea A. Zachary, Mary S. Leffell, Desensitization for solid organ and hematopoietic stem cell transplantation, Immunological Reviews, 2014, 258, 1
  19. 19
    A. Djamali, D. B. Kaufman, T. M. Ellis, W. Zhong, A. Matas, M. Samaniego, Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches, American Journal of Transplantation, 2014, 14, 2
  20. 20
    Mark D. Stegall, Natalie Moore, Timucin Taner, Han Li, Patrick G. Dean, Down-Regulating Humoral Immune Responses, Transplantation Journal, 2014, 97, 3, 247

    CrossRef

  21. 21
    B. E. Lonze, A. A. Zachary, C. M. Magro, N. M. Desai, B. J. Orandi, N. N. Dagher, A. L. Singer, N. Carter-Monroe, S. M. Nazarian, D. L. Segev, M. B. Streiff, R. A. Montgomery, Eculizumab Prevents Recurrent Antiphospholipid Antibody Syndrome and Enables Successful Renal Transplantation, American Journal of Transplantation, 2014, 14, 2
  22. 22
    Michael Kaabak, Nadezhda Babenko, Oleg Kuznetsov, Alexander Matveev, Marina Minina, Elena Platova, Margaret Morozova, Tatyana Novozhilova, Eculizumab reverses the potentially fatal effects of kidney graft reperfusion injury, Pediatric Transplantation, 2014, 18, 2
  23. 23
    Adnan Sharif, Edward S. Kraus, Andrea A. Zachary, Bonnie E. Lonze, Susanna M. Nazarian, Dorry L. Segev, Nada Alachkar, Lois J. Arend, Serena M. Bagnasco, Lorraine C. Racusen, Robert A. Montgomery, Histologic Phenotype on 1-Year Posttransplantation Biopsy and Allograft Survival in HLA-Incompatible Kidney Transplants, Transplantation, 2014, 97, 5, 541

    CrossRef

  24. 24
    David H Chang, Michelle M Kittleson, Jon A Kobashigawa, Immunosuppression following heart transplantation: prospects and challenges, Immunotherapy, 2014, 6, 2, 181

    CrossRef

  25. 25
    Jeffrey Saland, Liver–kidney transplantation to cure atypical HUS: still an option post-eculizumab?, Pediatric Nephrology, 2014, 29, 3, 329

    CrossRef

  26. 26
    Leonardo V. Riella, Kassem Safa, Jude Yagan, Belinda Lee, Jamil Azzi, Nader Najafian, Reza Abdi, Edgar Milford, Helen Mah, Steven Gabardi, Sayeed Malek, Stefan G. Tullius, Colm Magee, Anil Chandraker, Long-Term Outcomes of Kidney Transplantation Across a Positive Complement-Dependent Cytotoxicity Crossmatch, Transplantation, 2014, 97, 12, 1247

    CrossRef

  27. 27
    Conrad A. Farrar, Steven H. Sacks, Mechanisms of rejection, Current Opinion in Organ Transplantation, 2014, 19, 1, 8

    CrossRef

  28. 28
    Gianluigi Zaza, Paola Tomei, Simona Granata, Luigino Boschiero, Antonio Lupo, Monoclonal Antibody Therapy and Renal Transplantation: Focus on Adverse Effects, Toxins, 2014, 6, 3, 869

    CrossRef

  29. 29
    Mariana Wohlfahrtova, Ondrej Viklicky, Recent trials in immunosuppression and their consequences for current therapy, Current Opinion in Organ Transplantation, 2014, 19, 4, 387

    CrossRef

  30. 30
    Hariharan S. Iyer, Annette M. Jackson, Robert A. Montgomery, Sensitized Patients, Transplant, and Management, Current Transplantation Reports, 2014, 1, 2, 69

    CrossRef

  31. 31
    U. Maggiore, R. Oberbauer, J. Pascual, O. Viklicky, C. Dudley, K. Budde, S. S. Sorensen, M. Hazzan, M. Klinger, D. Abramowicz, Strategies to increase the donor pool and access to kidney transplantation: an international perspective, Nephrology Dialysis Transplantation, 2014,

    CrossRef

  32. 32
    C. Wehling, M. Kirschfink, Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis, Journal of Thrombosis and Haemostasis, 2014, 12, 8
  33. 33
    C.K. Burghuber, T.K. Roberts, S.J. Knechtle, The clinical relevance of alloantibody in liver transplantation, Transplantation Reviews, 2014,

    CrossRef

  34. 34
    Katarzyna Kościelska-Kasprzak, Dorota Bartoszek, Marta Myszka, Marcelina Żabińska, Marian Klinger, The Complement Cascade and Renal Disease, Archivum Immunologiae et Therapiae Experimentalis, 2014, 62, 1, 47

    CrossRef

  35. 35
    Simonetta Salemi, Milica Markovic, Gabriella Martini, Raffaele D'Amelio, The Expanding Role of Therapeutic Antibodies, International Reviews of Immunology, 2014, 140128114424000

    CrossRef

  36. 36
    William Hanf, Claudine S. Bonder, P. Toby H. Coates, Transplant Glomerulopathy: The Interaction of HLA Antibodies and Endothelium, Journal of Immunology Research, 2014, 2014, 1

    CrossRef

  37. 37
    E.K. Page, I.R. Badell, S.J. Knechtle, Pathobiology of Human Disease, 2014,

    CrossRef

  38. 38
    Nizam Mamode, Regenerative Medicine Applications in Organ Transplantation, 2014,

    CrossRef

  39. 39
    S. V. Niederhaus, G. E. Leverson, D. F. Lorentzen, D. J. Robillard, H. W. Sollinger, J. D. Pirsch, J. R. Torrealba, J. S. Odorico, Acute Cellular and Antibody-Mediated Rejection of the Pancreas Allograft: Incidence, Risk Factors and Outcomes, American Journal of Transplantation, 2013, 13, 11
  40. 40
    Sufia Husain, Banu Sis, Advances in the Understanding of Transplant Glomerulopathy, American Journal of Kidney Diseases, 2013, 62, 2, 352

    CrossRef

  41. 41
    Ke Li, Wuding Zhou, Anaphylatoxins in organ transplantation, Seminars in Immunology, 2013, 25, 1, 20

    CrossRef

  42. 42
    D. P. Gale, P. H. Maxwell, C3 glomerulonephritis and CFHR5 nephropathy, Nephrology Dialysis Transplantation, 2013, 28, 2, 282

    CrossRef

  43. 43
    M. B. van Werkhoven, J. Damman, M. C. R. F. van Dijk, M. R. Daha, I. J. de Jong, A. Leliveld, C. Krikke, H. G. Leuvenink, H. van Goor, W. J. van Son, P. Olinga, J.-L. Hillebrands, M. A. J. Seelen, Complement Mediated Renal Inflammation Induced by Donor Brain Death: Role of Renal C5a-C5aR Interaction, American Journal of Transplantation, 2013, 13, 4
  44. 44
    Paolo Cravedi, William van der Touw, Peter S. Heeger, Complement Regulation of T-Cell Alloimmunity, Seminars in Nephrology, 2013, 33, 6, 565

    CrossRef

  45. 45
    Alexandre Loupy, Carmen Lefaucheur, Dewi Vernerey, Christof Prugger, Jean-Paul Duong van Huyen, Nuala Mooney, Caroline Suberbielle, Véronique Frémeaux-Bacchi, Arnaud Méjean, François Desgrandchamps, Dany Anglicheau, Dominique Nochy, Dominique Charron, Jean-Philippe Empana, Michel Delahousse, Christophe Legendre, Denis Glotz, Gary S. Hill, Adriana Zeevi, Xavier Jouven, Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival, New England Journal of Medicine, 2013, 369, 13, 1215

    CrossRef

  46. 46
    Sebastian M Schaefer, Caner Süsal, Claudia Sommerer, Martin Zeier, Christian Morath, Current pharmacotherapeutical options for the prevention of kidney transplant rejection, Expert Opinion on Pharmacotherapy, 2013, 14, 8, 1029

    CrossRef

  47. 47
    J.M. Yabu, M.J. Pando, S. Busque, M.L. Melcher, Desensitization Combined With Paired Exchange Leads to Successful Transplantation in Highly Sensitized Kidney Transplant Recipients: Strategy and Report of Five Cases, Transplantation Proceedings, 2013, 45, 1, 82

    CrossRef

  48. 48
    B. Kocak, E. Arpali, E. Demiralp, B. Yelken, C. Karatas, S. Gorcin, N. Gorgulu, M. Uzunalan, A. Turkmen, M. Kalayoglu, Eculizumab for Salvage Treatment of Refractory Antibody-Mediated Rejection in Kidney Transplant Patients: Case Reports, Transplantation Proceedings, 2013, 45, 3, 1022

    CrossRef

  49. 49
    G. Canaud, N. Kamar, D. Anglicheau, L. Esposito, M. Rabant, L.-H. Noël, C. Guilbeau-Frugier, R. Sberro-Soussan, A. Del Bello, F. Martinez, J. Zuber, L. Rostaing, C. Legendre, Eculizumab Improves Posttransplant Thrombotic Microangiopathy Due to Antiphospholipid Syndrome Recurrence but Fails to Prevent Chronic Vascular Changes, American Journal of Transplantation, 2013, 13, 8
  50. 50
    Christophe Legendre, Rébecca Sberro-Soussan, Julien Zuber, Marion Rabant, Alexandre Loupy, Marc-Olivier Timsit, Dany Anglicheau, Eculizumab in renal transplantation, Transplantation Reviews, 2013, 27, 3, 90

    CrossRef

  51. 51
    Carla M. Nester, Patrick D. Brophy, Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases, Current Opinion in Pediatrics, 2013, 25, 2, 225

    CrossRef

  52. 52
    Ralf J. Ludwig, Kathrin Kalies, Jörg Köhl, Detlef Zillikens, Enno Schmidt, Emerging treatments for pemphigoid diseases, Trends in Molecular Medicine, 2013, 19, 8, 501

    CrossRef

  53. 53
    Cinthia B. Drachenberg, John C. Papadimitriou, Endothelial Injury in Renal Antibody-Mediated Allograft Rejection, Transplantation Journal, 2013, 95, 9, 1073

    CrossRef

  54. 54
    A. Ryckewaert, E. Allain-Launay, A. Moreau, G. Blancho, A. Cesbron, N. Blin, G. Roussey, Failure of bortezomib to cure acute antibody-mediated rejection in a non-compliant renal transplant patient, Pediatric Transplantation, 2013, 17, 6
  55. 55
    D. Abramowicz, P. Cochat, F. Claas, C. Dudley, P. Harden, U. Heeman, M. Hourmant, U. Maggiore, J. Pascual, M. Salvadori, G. Spasovski, J.-P. Squifflet, J. Steiger, A. Torres, R. Vanholder, W. Van Biesen, O. Viklicky, M. Zeier, E. Nagler, Guideline, Nephrology Dialysis Transplantation, 2013, 28, suppl 2, ii1

    CrossRef

  56. 56
    J. Cai, X. Qing, J. Tan, P. I. Terasaki, Humoral theory of transplantation: some hot topics, British Medical Bulletin, 2013, 105, 1, 139

    CrossRef

  57. 57
    Angelo A Leto Barone, Zhaoli Sun, Robert A Montgomery, WP Andrew Lee, Gerald Brandacher, Impact of donor-specific antibodies in reconstructive transplantation, Expert Review of Clinical Immunology, 2013, 9, 9, 835

    CrossRef

  58. 58
    Caner Süsal, Increasing relevance of histocompatibility testing in organ transplantation, Current Opinion in Organ Transplantation, 2013, 18, 4, 436

    CrossRef

  59. 59
    R. Sommaggio, M. Pérez-Cruz, J.L. Brokaw, R. Máñez, C. Costa, Inhibition of complement component C5 protects porcine chondrocytes from xenogeneic rejection, Osteoarthritis and Cartilage, 2013, 21, 12, 1958

    CrossRef

  60. 60
    Luis E. Becker, Caner Süsal, Christian Morath, Kidney transplantation across HLA and ABO antibody barriers, Current Opinion in Organ Transplantation, 2013, 1

    CrossRef

  61. 61
    Qiquan Sun, Yang Yang, Late and Chronic Antibody-Mediated Rejection: Main Barrier to Long Term Graft Survival, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  62. 62
    Basma Sadaka, Rita R. Alloway, E. Steve Woodle, Management of Antibody-Mediated Rejection in Transplantation, Surgical Clinics of North America, 2013, 93, 6, 1451

    CrossRef

  63. 63
    F. Halleck, F. Friedersdorff, T.F. Fuller, M. Matz, L. Huber, M. Dürr, M. Schütz, K. Budde, New Perspectives of Immunosuppression, Transplantation Proceedings, 2013, 45, 3, 1224

    CrossRef

  64. 64
    Maaike B. van Werkhoven, Jeffrey Damman, Mohamed R. Daha, Christina Krikke, Harry van Goor, Willem J. van Son, Jan-Luuk Hillebrands, Marcory C.R.F. van Dijk, Marc A.J. Seelen, Novel insights in localization and expression levels of C5aR and C5L2 under native and post-transplant conditions in the kidney, Molecular Immunology, 2013, 53, 3, 237

    CrossRef

  65. 65
    Amani Joudeh, Khouloud Ahmad Saliba, Kaila A. Topping, Banu Sis, Pathologic basis of antibody-mediated organ transplant rejection, Current Opinion in Organ Transplantation, 2013, 18, 4, 478

    CrossRef

  66. 66
    U. Heemann, J. Lutz, Pathophysiology and treatment options of chronic renal allograft damage, Nephrology Dialysis Transplantation, 2013, 28, 10, 2438

    CrossRef

  67. 67
    Lubka T. Roumenina, Julien Zuber, Véronique Frémeaux-Bacchi, Physiological and therapeutic complement regulators in kidney transplantation, Current Opinion in Organ Transplantation, 2013, 1

    CrossRef

  68. 68
    Lynn D. Cornell, Renal allograft pathology in the sensitized patient, Current Opinion in Organ Transplantation, 2013, 18, 3, 327

    CrossRef

  69. 69
    Gang Chen, Song Chen, Xiaoping Chen, Role of complement and perspectives for intervention in transplantation, Immunobiology, 2013, 218, 5, 817

    CrossRef

  70. 70
    Gregor Bartel, Markus Wahrmann, Elisabeth Schwaiger, Željko Kikić, Christine Winzer, Walter H. Hörl, Ferdinand Mühlbacher, Matthias Hoke, Gerhard J. Zlabinger, Heinz Regele, Georg A. Böhmig, Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients, Transplant International, 2013, 26, 2
  71. 71
    Souichi Shiratori, Makoto Ito, Maki Yoneoka, Koji Hayasaka, Eiko Hayase, Junko Iwasaki, Junichi Sugita, Akio Shigematsu, Katsuya Fujimoto, Takeshi Kondo, Chikara Shimizu, Takanori Teshima, Successful Engraftment in HLA-Mismatched Bone Marrow Transplantation Despite the Persistence of High-Level Donor-Specific Anti-HLA-DR Antibody, Transplantation Journal, 2013, 96, 5, e34

    CrossRef

  72. 72
    Julien Zuber, Moglie Le Quintrec, Heather Morris, Véronique Frémeaux-Bacchi, Chantal Loirat, Christophe Legendre, Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation, Transplantation Reviews, 2013, 27, 4, 117

    CrossRef

  73. 73
    Jennifer A. McCaughan, Declan M. O'Rourke, Aisling E. Courtney, The Complement Cascade in Kidney Disease: From Sideline to Center Stage, American Journal of Kidney Diseases, 2013, 62, 3, 604

    CrossRef

  74. 74
    Rosana Rosa Miranda Corrêa, Juliana Reis Machado, Marcos Vinícius da Silva, Fernanda Rodrigues Helmo, Camila Souza Oliveira Guimarães, Laura Penna Rocha, Ana Carolina Guimarães Faleiros, Marlene Antônia dos Reis, The Importance of C4d in Biopsies of Kidney Transplant Recipients, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  75. 75
    A. Nicholas R. Barnett, Elham Asgari, Paramit Chowdhury, Steven H. Sacks, Anthony Dorling, Nizam Mamode, The use of eculizumab in renal transplantation, Clinical Transplantation, 2013, 27, 3
  76. 76
    Hariharan S. Iyer, Annette M. Jackson, Andrea A. Zachary, Robert A. Montgomery, Transplanting the highly sensitized patient, Current Opinion in Nephrology and Hypertension, 2013, 22, 6, 681

    CrossRef

  77. 77
    Jan Schmidtko, Sven Peine, Youssef El-Housseini, Manuel Pascual, Pascal Meier, Treatment of Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathies: A Focus on Eculizumab, American Journal of Kidney Diseases, 2013, 61, 2, 289

    CrossRef

  78. 78
    Kwan-Tae Park, Cheol-Woong Jung, Myung-Gyu Kim, Update on the Treatment of Acute and Chronic Antibody-mediated Rejection, The Journal of the Korean Society for Transplantation, 2013, 27, 1, 6

    CrossRef

  79. 79
    D. Noone, J. Al-Matrafi, K. Tinckam, P. F. Zipfel, A. M. Herzenberg, P. S. Thorner, F. G. Pluthero, W. H. A. Kahr, G. Filler, D. Hebert, E. Harvey, C. Licht, Antibody Mediated Rejection Associated With Complement Factor H–Related Protein 3/1 Deficiency Successfully Treated With Eculizumab, American Journal of Transplantation, 2012, 12, 9
  80. 80
    Lynn D. Cornell, Mariam Priya Alexander, Mark D. Stegall, Antibody-Mediated Injury in the Renal Allograft, Pathology Case Reviews, 2012, 17, 6, 219

    CrossRef

  81. 81
    Chethan Puttarajappa, Ron Shapiro, Henkie P. Tan, Antibody-Mediated Rejection in Kidney Transplantation: A Review, Journal of Transplantation, 2012, 2012, 1

    CrossRef

  82. 82
    Sharon Chih, Andrzej Chruscinski, Heather J. Ross, Kathryn Tinckam, Jagdish Butany, Vivek Rao, Antibody-Mediated Rejection: An Evolving Entity in Heart Transplantation, Journal of Transplantation, 2012, 2012, 1

    CrossRef

  83. 83
    Olivia R. Blume, Sarah E. Yost, Bruce Kaplan, Antibody-Mediated Rejection: Pathogenesis, Prevention, Treatment, and Outcomes, Journal of Transplantation, 2012, 2012, 1

    CrossRef

  84. 84
    Thomas Fehr, Ariana Gaspert, Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale, Transplant International, 2012, 25, 6
  85. You have free access to this content85
    M. Mengel, B. Sis, M. Haas, R. B. Colvin, P. F. Halloran, L. C. Racusen, K. Solez, L. Cendales, A. J. Demetris, C. B. Drachenberg, C. F. Farver, E. R. Rodriguez, W. D. Wallace, D. Glotz, Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection, American Journal of Transplantation, 2012, 12, 3
  86. 86
    Eugenia K. Page, Wasim A. Dar, Stuart J. Knechtle, Biologics in organ transplantation, Transplant International, 2012, 25, 7
  87. 87
    Z.A. Stewart, T.E. Collins, A.J. Schlueter, T.I. Raife, D.G. Holanda, R. Nair, A.I. Reed, C.P. Thomas, Case Report: Eculizumab Rescue of Severe Accelerated Antibody-Mediated Rejection After ABO-Incompatible Kidney Transplant, Transplantation Proceedings, 2012, 44, 10, 3033

    CrossRef

  88. 88
    Julio Pascual, Maria J. Pérez-Sáez, Marisa Mir, Marta Crespo, Chronic renal allograft injury: early detection, accurate diagnosis and management, Transplantation Reviews, 2012, 26, 4, 280

    CrossRef

  89. 89
    M.N.M. Hezmee, I.A. Shiels, B.E. Rolfe, P.C. Mills, Complement C5a: Impact on the field of veterinary medicine, The Veterinary Journal, 2012, 192, 3, 264

    CrossRef

  90. 90
    Luuk B. Hilbrands, Current perspectives to overcome a positive crossmatch in living donor renal transplantation, Transplant International, 2012, 25, 5
  91. 91
    J. Zuber, M. Le Quintrec, S. Krid, C. Bertoye, V. Gueutin, A. Lahoche, N. Heyne, G. Ardissino, V. Chatelet, L.-H. Noël, M. Hourmant, P. Niaudet, V. Frémeaux-Bacchi, E. Rondeau, C. Legendre, C. Loirat, Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation, American Journal of Transplantation, 2012, 12, 12
  92. 92
    F. González-Roncero, M. Suñer, G. Bernal, V. Cabello, M. Toro, P. Pereira, M. Angel Gentil, Eculizumab Treatment of Acute Antibody-Mediated Rejection in Renal Transplantation: Case Reports, Transplantation Proceedings, 2012, 44, 9, 2690

    CrossRef

  93. 93
    Robert A. Montgomery, Daniel S. Warren, Dorry L. Segev, Andrea A. Zachary, HLA incompatible renal transplantation, Current Opinion in Organ Transplantation, 2012, 17, 4, 386

    CrossRef

  94. 94
    M. Berger, A. Zeevi, D. G. Farmer, K. M. Abu-Elmagd, Immunologic Challenges in Small Bowel Transplantation, American Journal of Transplantation, 2012, 12,
  95. 95
    Jignesh K Patel, Jon A Kobashigawa, Improving survival during heart transplantation: diagnosis of antibody-mediated rejection and techniques for the prevention of graft injury, Future Cardiology, 2012, 8, 4, 623

    CrossRef

  96. 96
    A. Sharif, N. Alachkar, E. Kraus, Incompatible kidney transplantation: a brief overview of the past, present and future, QJM, 2012, 105, 12, 1141

    CrossRef

  97. 97
    Dorry L. Segev, Innovative strategies in living donor kidney transplantation, Nature Reviews Nephrology, 2012, 8, 6, 332

    CrossRef

  98. 98
    Stephen D. Marks, New immunosuppressants in pediatric solid organ transplantation, Current Opinion in Organ Transplantation, 2012, 17, 5, 503

    CrossRef

  99. 99
    Michael Mengel, Sufia Husain, Luis Hidalgo, Banu Sis, Phenotypes of antibody-mediated rejection in organ transplants, Transplant International, 2012, 25, 6
  100. 100
    Christian Morath, Gerhard Opelz, Martin Zeier, Caner Süsal, Prevention of antibody-mediated kidney transplant rejection, Transplant International, 2012, 25, 6
  101. 101
    Danielle Cohen, Robert B Colvin, Mohamed R Daha, Cinthia B Drachenberg, Mark Haas, Volker Nickeleit, Jane E Salmon, Banu Sis, Ming-Hui Zhao, Jan A Bruijn, Ingeborg M Bajema, Pros and cons for C4d as a biomarker, Kidney International, 2012, 81, 7, 628

    CrossRef

  102. 102
    C. Morath, G. Opelz, M. Zeier, C. Süsal, Recent Developments in Desensitization of Crossmatch-positive Kidney Transplant Recipients, Transplantation Proceedings, 2012, 44, 6, 1648

    CrossRef

  103. 103
    S. Krid, LT. Roumenina, D. Beury, M. Charbit, O. Boyer, V. Frémeaux-Bacchi, P. Niaudet, Renal Transplantation Under Prophylactic Eculizumab in Atypical Hemolytic Uremic Syndrome With CFH/CFHR1 Hybrid Protein, American Journal of Transplantation, 2012, 12, 7
  104. 104
    Takurin Akiyoshi, Tsutomu Hirohashi, Alessandro Alessandrini, Catherine M. Chase, Evan A. Farkash, R. Neal Smith, Joren C. Madsen, Paul S. Russell, Robert B. Colvin, Role of complement and NK cells in antibody mediated rejection, Human Immunology, 2012, 73, 12, 1226

    CrossRef

  105. 105
    J. A. Kobashigawa, The Future of Heart Transplantation, American Journal of Transplantation, 2012, 12, 11
  106. 106
    Alexandre Loupy, Gary S. Hill, Stanley C. Jordan, The impact of donor-specific anti-HLA antibodies on late kidney allograft failure, Nature Reviews Nephrology, 2012, 8, 6, 348

    CrossRef

  107. 107
    Brian K. Goh, Marcio F. Chedid, James M. Gloor, Suresh Raghavaiah, Mark D. Stegall, The impact of terminal complement blockade on the efficacy of induction with polyclonal rabbit antithymocyte globulin in living donor renal allografts, Transplant Immunology, 2012, 27, 2-3, 95

    CrossRef

  108. 108
    Mark D. Stegall, Marcio F. Chedid, Lynn D. Cornell, The role of complement in antibody-mediated rejection in kidney transplantation, Nature Reviews Nephrology, 2012, 8, 11, 670

    CrossRef

  109. 109
    Steven H. Sacks, Wuding Zhou, The role of complement in the early immune response to transplantation, Nature Reviews Immunology, 2012, 12, 6, 431

    CrossRef

  110. 110
    Julien Zuber, Fadi Fakhouri, Lubka T. Roumenina, Chantal Loirat, Véronique Frémeaux-Bacchi, Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nature Reviews Nephrology, 2012, 8, 11, 643

    CrossRef

  111. 111
    L. Weekers, What's New in Renal and Pancreatic Transplantation in 2011?, Transplantation Proceedings, 2012, 44, 9, 2784

    CrossRef

  112. 112
    Lars P Kihm, Martin Zeier, Christian Morath, Emerging drugs for the treatment of transplant rejection, Expert Opinion on Emerging Drugs, 2011, 16, 4, 683

    CrossRef

  113. You have free access to this content113
    E. S. Woodle, W. M. Baldwin III, Of Mice and Men: Terminal Complement Inhibition With Anti-C5 Monoclonal Antibodies, American Journal of Transplantation, 2011, 11, 11
  114. 114
    Nizam Mamode, Antibody-Incompatible Transplantation,
  115. 115
    Jesse D. Schold, S. Joseph Kim, Clinical Research Methods and Analysis in Organ Transplantation,
  116. 116
    Carmen Lefaucheur, Denis Glotz, Desensitization Protocols for Organ Transplantation,
  117. 117
    Allison B. Webber, Flavio Vincenti, Future Pathways for Immune Manipulation,
  118. 118
    Alton Brad Farris, III, Michael H. Mengel, Histopathological Syndromes of Kidney Allograft Rejection and Recurrent Disease,
  119. 119
    William M. Baldwin, Robert L. Fairchild, Humoral Mechanisms of Adaptive Immunity,
  120. 120
    Mark D. Stegall, Patrick G. Dean, Rescue Immunosuppressive Therapy,
  121. 121
    Roger Sciammas, Anita S. Chong, Robert B. Colvin, The B Cell Response to Transplantation Antigens,